Cargando…
Fibromyalgia and mortality: a systematic review and meta-analysis
OBJECTIVE: To conduct a systematic review of the literature on the association between fibromyalgia and mortality and to pool the results in a meta-analysis. METHODS: The authors searched the PubMed, Scopus, and Web of Science databases using the key words ‘fibromyalgia’ and ‘mortality’ to identify...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335452/ https://www.ncbi.nlm.nih.gov/pubmed/37429737 http://dx.doi.org/10.1136/rmdopen-2023-003005 |
_version_ | 1785071003122008064 |
---|---|
author | Treister-Goltzman, Yulia Peleg, Roni |
author_facet | Treister-Goltzman, Yulia Peleg, Roni |
author_sort | Treister-Goltzman, Yulia |
collection | PubMed |
description | OBJECTIVE: To conduct a systematic review of the literature on the association between fibromyalgia and mortality and to pool the results in a meta-analysis. METHODS: The authors searched the PubMed, Scopus, and Web of Science databases using the key words ‘fibromyalgia’ and ‘mortality’ to identify studies that addressed an association between fibromyalgia and mortality. Original papers that assessed associations between fibromyalgia and mortality (all or specific causes) and provided an effect measure (hazard ratio (HR), standardised mortality ratio (SMR), odds ratio (OR)) quantifying the relationship between fibromyalgia and mortality were included in the systematic review. Of 557 papers that were initially identified using the search words, 8 papers were considered eligible for the systematic review and meta-analysis. We used a Newcastle-Ottawa scale to assess the risk of bias in the studies. RESULTS: The total fibromyalgia group included 188 751 patients. An increased HR was found for all-cause mortality (HR 1.27, 95% CI 1.04 to 1.51), but not for the subgroup diagnosed by the 1990 criteria. There was a borderline increased SMR for accidents (SMR 1.95, 95% CI 0.97 to 3.92), an increased risk for mortality from infections (SMR 1.66, 95% CI 1.15 to 2.38), and suicide (SMR 3.37, 95% CI 1.52 to 7.50), and a decreased mortality rate for cancer (SMR 0.82, 95% CI 0.69 to 0.97). The studies showed significant heterogeneity. CONCLUSIONS: These potential associations indicate that fibromyalgia should be taken seriously, with a special focus on screening for suicidal ideation, accident prevention, and the prevention and treatment of infections. |
format | Online Article Text |
id | pubmed-10335452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-103354522023-07-12 Fibromyalgia and mortality: a systematic review and meta-analysis Treister-Goltzman, Yulia Peleg, Roni RMD Open Epidemiology OBJECTIVE: To conduct a systematic review of the literature on the association between fibromyalgia and mortality and to pool the results in a meta-analysis. METHODS: The authors searched the PubMed, Scopus, and Web of Science databases using the key words ‘fibromyalgia’ and ‘mortality’ to identify studies that addressed an association between fibromyalgia and mortality. Original papers that assessed associations between fibromyalgia and mortality (all or specific causes) and provided an effect measure (hazard ratio (HR), standardised mortality ratio (SMR), odds ratio (OR)) quantifying the relationship between fibromyalgia and mortality were included in the systematic review. Of 557 papers that were initially identified using the search words, 8 papers were considered eligible for the systematic review and meta-analysis. We used a Newcastle-Ottawa scale to assess the risk of bias in the studies. RESULTS: The total fibromyalgia group included 188 751 patients. An increased HR was found for all-cause mortality (HR 1.27, 95% CI 1.04 to 1.51), but not for the subgroup diagnosed by the 1990 criteria. There was a borderline increased SMR for accidents (SMR 1.95, 95% CI 0.97 to 3.92), an increased risk for mortality from infections (SMR 1.66, 95% CI 1.15 to 2.38), and suicide (SMR 3.37, 95% CI 1.52 to 7.50), and a decreased mortality rate for cancer (SMR 0.82, 95% CI 0.69 to 0.97). The studies showed significant heterogeneity. CONCLUSIONS: These potential associations indicate that fibromyalgia should be taken seriously, with a special focus on screening for suicidal ideation, accident prevention, and the prevention and treatment of infections. BMJ Publishing Group 2023-06-07 /pmc/articles/PMC10335452/ /pubmed/37429737 http://dx.doi.org/10.1136/rmdopen-2023-003005 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Epidemiology Treister-Goltzman, Yulia Peleg, Roni Fibromyalgia and mortality: a systematic review and meta-analysis |
title | Fibromyalgia and mortality: a systematic review and meta-analysis |
title_full | Fibromyalgia and mortality: a systematic review and meta-analysis |
title_fullStr | Fibromyalgia and mortality: a systematic review and meta-analysis |
title_full_unstemmed | Fibromyalgia and mortality: a systematic review and meta-analysis |
title_short | Fibromyalgia and mortality: a systematic review and meta-analysis |
title_sort | fibromyalgia and mortality: a systematic review and meta-analysis |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335452/ https://www.ncbi.nlm.nih.gov/pubmed/37429737 http://dx.doi.org/10.1136/rmdopen-2023-003005 |
work_keys_str_mv | AT treistergoltzmanyulia fibromyalgiaandmortalityasystematicreviewandmetaanalysis AT pelegroni fibromyalgiaandmortalityasystematicreviewandmetaanalysis |